TNFSF10 and prostate carcinoma: Activation of TRPM7 promotes prostate cancer cell proliferation, migration, and viability [10, 11], while inhibition of TRPM7 by Gd3+ or 2-aminoethoxy diphenylborate (2-APB) enhances TRAIL-induced PC-3 cell apoptosis [12].